Decoding the YC SAFE: A Term-by-Term Guide

Early-stage fundraising moves quickly. Founders and investors sometimes sign Simple Agreements for Future Equity (SAFEs) within days of meeting, with minimal legal negotiation and low transaction costs. That speed is the point, but it can also obscure the complexities of how these instruments work.

Today, the Y Combinator (YC) post-money SAFE is widely used for early-stage fundraising and bridge rounds. Despite its brevity, it contains a set of defined terms that are essential for founders and investors to understand.

This post walks through the key terms in the YC SAFE and draws out the practical implications for both sides.

Background

YC introduced the original SAFE in 2013 as a faster, simpler alternative to convertible notes for early-stage financings. Unlike convertible notes, SAFEs do not accrue interest and have no maturity date, which means there is no deadline by which the company must repay or convert the instrument. They are not debt; they are equity instruments from inception. This avoids the awkward dynamic that arises when a convertible note matures before a priced round closes, forcing founders into extension negotiations or unintended scenarios.

It is important to understand what a SAFE is not. A SAFE is not stock. Holding a SAFE doesn’t make the investor a stockholder or confer voting or any other governance rights. The SAFE holder has no rights other than the economic rights described in the SAFE itself. The SAFE simply sits on the cap table as an outstanding convertible instrument until a triggering event occurs, typically the company's next priced financing round, at which point it converts into actual shares of preferred stock and the holder becomes a stockholder with all the attendant rights.

The key term affecting dilution is how many shares the SAFE holder will receive upon conversion. The SAFE has a set of conversion mechanics described below, beginning with the valuation cap.

Valuation Cap

Most SAFEs have a “valuation cap”, which sets the maximum valuation at which the SAFE will convert into equity in the company’s next financing round. The valuation cap functions as a ceiling on the price at which the SAFE converts into equity in a priced round. If the company's financing round is priced at a valuation above the cap, SAFE holders convert at the lower (capped) price and receive more shares per dollar invested. If the priced round valuation is at or below the cap, the cap is irrelevant and the SAFE converts at the round price.

Valuation caps come in two forms: pre-money and post-money. The distinction has meaningful implications for founder dilution, but before exploring those mechanics, it is worth briefly reviewing the triggering event that causes a SAFE to convert: an Equity Financing.

Equity Financing

An Equity Financing is the primary triggering event for SAFE conversion. When the company sells shares of preferred stock in a priced round, the outstanding SAFEs will convert into shares of preferred stock. The conversion of a SAFE in an Equity Financing is mandatory and automatic (though SAFE holders still typically sign the financing documentation in the round as they become stockholders) and the SAFE then terminates.

The resulting shares generally carry substantially the same economic and governance rights as the preferred stock sold in the financing. If the SAFE converts at the same price paid by the new investors, the SAFE holder typically receives the same series of preferred stock purchased in the round. If the SAFE converts at a discounted price due to a valuation cap or discount, the SAFE may instead convert into a separate series of “shadow preferred” stock designed to preserve the economic benefit of the lower conversion price while otherwise mirroring and/or sharing in the rights and preferences of the new preferred stock.

“Pre-Money” vs. “Post-Money”

The current YC SAFE form is the “post-money” form. However, the original YC SAFE used a “pre-money” valuation cap, meaning the cap represented the company's valuation immediately before any SAFE investments, rather than after. On the surface the distinction sounds technical, but in practice it had significant consequences for ownership predictability.

The distinction ultimately comes down to how the SAFE defines "Company Capitalization," the denominator used to calculate the SAFE's conversion price. Under the original pre-money SAFE, the Company Capitalization definition excluded other outstanding SAFEs and certain convertible securities that would also be converting in the future Equity Financing. As a result, the ownership associated with any particular SAFE could not be determined simply by looking at that SAFE in isolation, since it depended in part on how much additional SAFE (or other convertible) money the company raised before the next priced round.

In a pre-money SAFE, the answer to "how much of the company are we selling?" (and, conversely, "how much of the company are we getting?") therefore depends on a recursive loop including how much was raised on other SAFEs (plus a hypothetical assumption about the option pool increase that would be negotiated in the future financing in which the SAFEs were to convert). Each additional SAFE issued before the Equity Financing effectively changes the ownership outcome for everyone.

YC updated the SAFE to the post-money format in 2018 specifically to address these issues, making ownership more transparent and calculable at the time of each investment. In the post-money SAFE, the “Company Capitalization” definition includes all outstanding SAFEs and other convertible instruments that will convert in the Equity Financing.

The result is that a SAFE investor's ownership is easier to calculate when the SAFE is signed, since additional SAFEs issued later will dilute the common stockholders rather than the earlier SAFE holders. If a founder raises $500,000 at a $5 million Post-Money Valuation Cap, the implied ownership sold is exactly $500,000 / $5,000,000 = 10% (assuming the Equity Financing that eventually converts the SAFE into equity meets or exceeds that cap). That calculation requires no assumptions about how many other SAFEs will be issued. The SAFE round can therefore be planned and tracked in a similar way a priced seed round would be tracked.

One important nuance: the Post-Money Valuation Cap is "post" all of the SAFE money, but it is not also "post" the Equity Financing money. The result is that while the SAFEs are not diluted by each other, the SAFEs will be diluted by the new money raised in the Equity Financing.

Beware of “Stacking” Post-Money SAFEs

While the post-money SAFE arguably makes many calculations more straight forward, Founders must still be cautious about issuing SAFEs, and in particular about "stacking" multiple post-money SAFE rounds at different valuation caps. Because the “Company Capitalization” definition includes all outstanding SAFEs and other convertible instruments that will convert in the Equity Financing, each new SAFE issued at a higher cap converts at a price that already accounts for the dilutive effect of the earlier, lower-capped SAFEs sitting in the denominator. The earlier SAFEs, which convert at a lower cap, generate more shares per dollar invested.

To illustrate the compounding effect of stacked SAFEs: A founder who raises a $1 million SAFE at a $5 million cap, then a $1 million SAFE at a $10 million cap, then a $1 million SAFE at a $15 million cap, has not sold 20% + 10% + 6.7%. Rather, they have sold those percentages of a cap table that includes all three tranches in the denominator, and the aggregate dilution to common stockholders is greater than the simple sum of the individual implied ownership percentages might suggest.

Before signing a new SAFE at an increased valuation cap, founders are advised to model the full conversion waterfall across all outstanding tranches to understand the true aggregate dilution to the existing stockholders.

Discount Rate

While the valuation cap is the most common economic term in early-stage SAFEs, it is not the only pricing mechanism available. The SAFE can include a discount to the priced round price, either as a standalone term or in combination with a valuation cap.

The Discount Rate applies to the price per share of the preferred stock sold in the Equity Financing and is framed as 100 minus the discount percent. For example, a 20% discount off the price per share of the Preferred Stock sold in the Equity Financing equals a Discount Rate of 80%.

In the Discount-Only version of the SAFE, the investor converts at the discounted price regardless of the company's valuation at the time of the priced round. In the version of the SAFE with both a Valuation Cap and a Discount Rate, either the cap or the discount applies when converting the SAFE into shares of stock in an Equity Financing, depending on which calculation is most advantageous to the investor.

The Discount-Only SAFE is less common in early-stage practice because it provides no ceiling on the conversion valuation. For founders, this is the appeal: there is no cap that locks in a specific ownership percentage at conversion, which means the founder retains more upside if the company grows significantly before the priced round. For investors, the discount provides some compensation for early-stage risk, but without a valuation cap there is no guarantee that the effective conversion price will reflect the risk taken at the time of investment, particularly if the company raises its priced round at a high valuation.

The Cap and Discount version of the SAFE combines both mechanisms into a single instrument. At conversion, the investor receives whichever calculation produces more shares: conversion at the capped price or conversion at the discounted price. This gives the investor protection in both directions. If the priced round valuation is high, the valuation cap kicks in and ensures the investor converts at a price that reflects the risk taken at the time of the original investment. If the priced round valuation is relatively low (at or near the cap), the discount applies and the investor still converts at a better price than the new investors in the round.

The cap-and-discount structure represents the most investor-favorable version of the SAFE, and it is worth understanding that granting both terms means the investor benefits regardless of which direction the company's valuation moves between the SAFE and the priced round.

Sale of the Company

If the company is acquired before it raises an Equity Financing, this triggers what the SAFE calls a “Liquidity Event”, and at that point each SAFE holder is automatically entitled to receive the greater of two amounts: the original Purchase Amount back in cash, or the amount they would receive if they converted into common stock and participated in the sale proceeds alongside other equity holders. The investor receives whichever is higher.

In economic terms, this means the SAFE operates like preferred stock with a 1x non-participating liquidation preference: the investor is guaranteed at least a return of their investment, but can elect the as-converted upside if the sale price makes that more valuable. The SAFE holder is therefore not disadvantaged by the fact that the company has not yet completed a priced round.

It is worth distinguishing the sale scenario from a wind-down. If the company dissolves or winds up its operations before a priced round, SAFE holders are entitled to receive only their original Purchase Amount back, not the as-converted upside. In the liquidation priority waterfall, SAFE holders rank senior to common stockholders but on par with preferred stockholders and other SAFE holders.

Most Favored Nation (MFN)

Sometimes the SAFE will not include a valuation cap and/or a discount, and instead it will have a Most Favored Nation (MFN) provision. This structure is most commonly used for the very earliest capital into a company, before the founders have enough traction or market signal to set a valuation cap with confidence. If the company subsequently issues SAFEs with provisions that would be advantageous to investors holding the MFN SAFE (such as a valuation cap and/or a discount rate), the investor may choose to amend its SAFE to reflect the terms of the later-issued SAFEs.

For investors, the MFN provision is a meaningful protection. It allows an early, uncapped investor to benefit from better terms negotiated by later investors rather than being locked into a less favorable instrument. For founders, however, the MFN creates a contingent obligation that needs to be tracked carefully: issuing a subsequent capped SAFE can trigger amendment rights across all outstanding MFN SAFEs, with the result that early investors who came in without a cap can elect to receive one, meaningfully affecting the cap table in ways that may not have been fully anticipated at the time of the original issuance.

Pro Rata Rights (Side Letter)

Pro rata rights, or the right to participate in future financings, are not a default term in the SAFE. Instead, YC created a separate, optional Pro Rata Side Letter that companies can offer to investors at their discretion.

The pro rata right entitles SAFE holders to subscribe for a percentage of the total Equity Financing equivalent to their as-converted ownership. For example, if a fund invested $750,000 at a $5 million Post-Money Valuation Cap, that investor would be entitled to invest ~15% of the financing round.

Investors, particularly institutional venture capital funds, often ask for pro rata rights because the SAFE's conversion mechanics guarantee them a specific ownership percentage only up to the point of the Equity Financing. Once new money enters in the priced round, all existing holders (including converted SAFE holders) are diluted. A pro rata right allows the investor to participate in the Equity Financing by purchasing additional shares at the round price, thereby maintaining their ownership percentage rather than being diluted down. For a fund with a portfolio construction model that depends on owning a target percentage of each company at the Series A, the pro rata right is often a prerequisite to making the initial SAFE investment.

The decision to extend pro rata rights deserves careful consideration. When putting together the Equity Financing round, founders will have to make room for new investors, existing investors with pro rata rights, and perhaps existing investors without formal pro rata rights whom they nonetheless want in the round. Founders who have not carefully considered the pro rata rights they previously extended to investors may end up taking more dilution than anticipated in order to accommodate all allocations. Founders should think through how pro rata allocations might play out in an Equity Financing before agreeing to grant them during the SAFE fundraise.

Common approaches to managing pro rata right allocation include requiring a minimum investment amount to qualify, or back-solving from a target maximum aggregate pro rata allocation in the next round. 

Practical Takeaways

The YC post-money SAFE achieves something that is difficult in legal drafting: it is short, fast, and inexpensive to execute, while encoding a precise set of economic mechanics that determine outcomes across a wide range of scenarios.

For founders, the most important discipline is tracking the aggregate impact of SAFE issuances in real time. Because the post-money structure fixes each investor's ownership percentage at the time of investment, all dilution from subsequently issued SAFEs is absorbed by the founders and other common stockholders, not by earlier SAFE holders. The more a company raises on post-money SAFEs, the more of the founders' own equity is given away.

The biggest advantage of the post-money SAFE is that this dilution is immediately transparent and, in most cases, reasonably calculable. Both sides, but especially founders, should use that transparency to their benefit. Know the sum of implied as-converted ownership across all outstanding SAFEs before signing each new one, and model the downstream cap table at conversion before entering a priced round process.

For investors, the post-money framing is a structural advantage. Because the Post-Money Valuation Cap includes all converting securities in the denominator, each SAFE investor's ownership percentage is fixed at the time of investment and is not diluted by subsequently issued SAFEs. Instead, that dilution falls entirely on the founders and other common stockholders. The post-money SAFE effectively guarantees the investor a minimum ownership floor, which is genuinely valuable compared to the pre-money instrument where an investor's eventual ownership could be eroded by later SAFE issuances without their knowledge or consent.

On specific terms: negotiate the Post-Money Valuation Cap carefully, because it is the primary lever through which early-stage risk is priced. Be deliberate about which investors receive pro rata side letters, because the aggregate pro rata obligation can meaningfully constrain a future round's allocation. And if you are issuing MFN SAFEs, track your subsequent SAFEs carefully. Every new SAFE you issue can trigger amendment rights for existing MFN holders, with cap table consequences that can compound across multiple issuances if left unmonitored.

The SAFE’s brevity is a feature, but it does not eliminate the need to understand what each term does. The provisions discussed above determine who gets paid, how much, and on what timeline. Founders and investors who understand them are in a significantly better position when the moments that matter actually arrive.

This post is intended for informational purposes only and does not constitute legal advice. If you have questions about how SAFEs fit into your fundraising strategy, cap table, or a specific transaction, please reach out.

Next
Next

Founder’s Guide to Fundraising Readiness